Raman spektroskopisi ve makine öğrenimi analizini kullanarak Lewy vücut demansında modifiye edilmiş ⁇ -sinüklein tohum amplifikasyon analizi.

Araştırma özeti

Aşağıdaki metin kaynak makalenin lisansı doğrulanmış orijinal özetidir. cc by

BackgroundLewy body dementias (LBD), comprising dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD), are defined by misfolded α-synuclein aggregation. Seed amplification assays (SAAs), such as RT-QuIC, enable sensitive detection of α-synuclein aggregates but typically provide binary readouts and require fluorescence labeling. Raman spectroscopy offers a label-free approach to detect subtle biochemical changes, and its diagnostic potential can be enhanced with machine learning.ObjectivesThis proof-of-concept study aimed to evaluate whether Raman spectroscopy combined with machine learning can improve SAA-based discrimination of LBD from controls in cerebrospinal fluid (CSF).MethodsWe analyzed a small number of post-mortem CSF samples from pathologically confirmed DLB (n = 2), PDD (n = 2), and controls (n = 2) using a 7-day SAA. Raman spectra were collected on Days 1, 4, and 7 and analyzed using principal component analysis (PCA) and uniform manifold approximation and projection (UMAP).ResultsFollowing SAA, both PCA and UMAP distinguished combined LBD samples from controls within 24 h (Day 1), reflecting biochemical changes consistent with α-synuclein fibrillation. Spectral shifts indicated decreased α-helical content with increased β-sheet structures. No consistent separation between DLB and PDD was observed.ConclusionThis preliminary study demonstrates that combining Raman spectroscopy with machine learning can enable rapid, label-free detection of disease-specific changes. Despite the very limited sample size, these findings highlight the potential of this novel workflow and strongly warrant its validation in larger cohorts.

İlgili konular